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SUMMARY 
Background: The Thinking Healthy Programme (THP) is a psychological intervention recommended for 
the treatment of perinatal depression. We assessed the effectiveness and cost-effectiveness of THP 
delivered by peers (THPP) in Goa, India. 
Methods: In this single-blind, individually-randomised controlled trial, we recruited pregnant women 
aged ≥18 years attending antenatal clinics, who scored ≥10 on the Patient Health Questionnaire (PHQ-
9). Participants were randomly allocated (1:1) to THPP plus enhanced usual care (EUC), or to EUC alone 
in randomly-sized blocks, stratified by area of residence. Allocation was concealed using sequentially-
numbered opaque envelopes. Primary outcomes were severity of depressive symptoms (PHQ-9 score) 
and remission (PHQ-9 score <5) 6 months post-birth assessed by researchers masked to the treatment 
allocation. Analyses were by intention to treat, adjusting for covariates defined a priori or that showed 
imbalance at baseline. The trial is registered with ClinicalTrials.gov (NCT02104232). 
Findings: 280 women were enrolled between 24th October 2014 and 22nd June 2016 (140 per 
group). At 6 months, 122 (87%) and 129 (92%) women in the THPP plus EUC, and EUC alone  groups, 
respectively, contributed primary outcome data. There was evidence of higher prevalence of 
remission at 6 months in the THPP plus EUC versus EUC alone group (n=89 (73%) versus n=77 (60%), 
respectively; prevalence ratio (PR)=1·21; 95% confidence interval (CI) 1·01 to 1·45, p=0·04), but 
weaker evidence for lower symptom severity (mean 3·47, standard deviation (SD) 4·49 versus 4·48 
(SD=5·11), respectively; standardised mean difference (SMD)=-0·18; 95% CI -0·43 to 0·07, 
p=0·16).Repeated measures analyses over the duration of the trial (measured at 3 and 6 months 
post-birth) showed beneficial effects on symptom severity (SMD -0·37, 95% CI -0·88 to -0·24, p=0·01), 
remission (PR=1·21, 95% CI 1·01 to 1·41, p=0·02), WHO-Disability Assessment Schedule (WHO-DAS) 
scores (SMD=-0·32, 95% CI -0·76 to -0·21, p=0·02) and Multidimensional Scale of Perceived Social 
Support (MSPSS) scores (SMD=0·51, 95% CI 0·43 to 1·20, p=0·02). . The incremental societal cost per 
unit improvement on PHQ-9 was –US$ 29·64 (95% CI-32·88 to -26·41) at 3 months, and –US$93·53 
(95% CI -180·21 to -6·84) for the whole duration of the trial, with a 87% likelihood of being cost-
saving in the study setting. The mean cost of providing THPP was US$ 1·36 per beneficiary (95% CI 
1·32 to 1·39). There was no evidence of differences in serious adverse events by group, except 
stigmatisation was more often reported in the EUC alone (9%) versus the THPP plus EUC group (4%; 
p=0·08).  
 
Interpretation: THPP had a moderate effect on symptom severity and remission from perinatal 
depression over the 6 month post-natal period. THPP is relatively cheap to deliver and pays for itself 
through reduced health care, time and productivity costs. 
Funding: NIMH  
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INTRODUCTION 
 
Depression, the leading cause of disability worldwide,1 is a major contributor to the overall global 
burden of disease in women. Perinatal depression, defined as depression occurring during 
pregnancy or within the first year postpartum,2 affects between 5-25% of women.3 Perinatal 
depression has been associated with an array of negative child outcomes ranging from impaired 
physical health to poor neurodevelopmental and behavioural outcomes.4 
 
In many low-resource settings, perinatal depression is largely undiagnosed and untreated, due to 
human resource constraints and ill-equipped health systems, leaving over 90% of those in need 
untreated.5 Psychological interventions for perinatal depression in low and middle-income 
countries have shown to be effective when delivered by non-specialist providers.6 The Thinking 
Healthy Programme (THP) is such a programme for perinatal depression and is the first “low-
intensity” psychological intervention recently adopted by the World Health Organization (WHO).7 
The active ingredient of THP is based on cognitive behavior therapy (CBT) and includes strategies 
incorporating behavioural activation, active listening, collaboration with the family, guided 
discovery and homework. THP - delivered by female community health workers (CHWs) - more 
than halved the prevalence of perinatal depression among women in a large community-based 
randomised controlled trial in Pakistan.8 Despite the effectiveness shown, competing demands of 
CHWs have greatly limited their role in scaling up the THP.9 
 
The aim of the THP delivered by peers (THPP) programme was to modify THP for delivery by trained 
peer counsellors (referred to as ‘Sakhis’ in the Indian study setting) and to evaluate its effectiveness 
and cost-effectiveness compared to enhanced usual care (EUC).10 By using Sakhis we intend to 
improve scalability of this intervention by demonstrating the feasibility and effectiveness of task-
sharing to a wider range of non-specialist providers. We adapted the intervention for 
implementation in two diverse rural and peri-urban contexts in South Asia (India and Pakistan).11 
In this paper, we describe the findings of the trial in India where THPP was delivered through 
individual sessions. The results of the Pakistan trial, which delivered THPP through both individual 
and group sessions, are reported in the companion paper.12 
 
 
METHODS 
Setting 
The study was conducted in the north district of the state of Goa. Its population of 1.46 million makes 
Goa one of India's smallest states, with 62.2% of the population living in urban areas.13 Goa has a high 
literacy rate (male 92.6%, female 84.2%), an even gender ratio (50.7% male, 49.3% female)13 and a 
fertility rate of 1.8 per woman.14 The most widely spoken language is Konkani, followed by Marathi, 
Hindi and English. Public healthcare is provided through a network of healthcare providers working in 
urban primary health centres, sub-centres, community health centres and a district hospital.15 
Antenatal care coverage is high in India with 89% of women attending at least four antenatal care 
visits (urban areas 91%; rural areas 86%).16 
 
Study design and participants  
THPP in India was a single-blind, individually-randomised controlled trial. Participants were women in 
their second or third trimester of pregnancy aged ≥18 years, recruited from two antenatal clinics and 
two primary health centres. Participants who did not speak Konkani, Hindi or Marathi, or who were in 
need of immediate medical or psychiatric inpatient care were not eligible. Potentially eligible 
participants were screened for depression with a locally-validated version of the Patient Health 
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Questionnaire 9 (PHQ-9) after providing written informed consent for screening (or witnessed 
informed consent/audio-recordings for illiterate participants). Women who screened positive (PHQ-9 
score ≥10) were eligible for enrolment. The PHQ-9 cut-off score of ≥  10 has shown a positive predictive 
value of 5517  , and has previously been used in the study context.18 Ethical approval was obtained 
from the Institutional Review Boards (IRBs) at the London School of Hygiene and Tropical Medicine, 
Sangath (the implementing institution in India), and the Indian Council of Medical Research. The study 
protocol has been published previously.10 
Randomisation and masking 
Eligible, consenting participants were randomised to either THPP plus EUC or EUC alone using a 1:1 
allocation ratio. The randomisation list, in randomly-sized blocks of four or six stratified by area of 
residence (urban/rural), was generated by an independent statistician. The randomisation code was 
concealed and allocated using sequentially-numbered opaque sealed envelopes,19 an allocation 
concealment scheme which has been used successfully in previous trials in this setting.18 Research 
assistants opened the envelopes immediately after consent for enrolment and the baseline 
questionnaire had been completed, and assigned participants to the THPP plus EUC or EUC alone 
groups. Daily cross-checks were done by the data manager to check that allocations were consistent 
with the allocation code. Independent outcome assessors and the gynaecologists providing care to 
participants in both arms were masked to treatment allocation of the participant. Outcome assessors 
had no interaction with the study team. All members of the Trial Steering Committee (TSC), except 
the data manager (ED), remained masked to the allocation status until the data were unmasked after 
interpretation of the results at a TSC meeting on 23 October 2017. 
 
Procedures  
After enrolment and before randomisation, a baseline socio-demographic questionnaire was 
administered to participants to collect data on potential moderators of treatment effects (including 
age, participant’s treatment expectations, chronicity and severity of depression)20.  
Treatment as usual was enhanced as usual care for perinatal depression in India is no care at all. 
Participants in the EUC alone group received standard care from the gynaecologist plus enhanced 
treatment: (1) patients and gynaecologists were informed that the participant screened positive for 
depression; (2) gynaecologists were given the adapted mental health Gap Action Programme (mhGAP) 
treatment guidelines for perinatal depression which included information on how to refer severe 
cases and patients with suicide risk to specialist mental health care; and (3) participants were provided 
with an information sheet including details on where to seek appropriate health care during pregnancy 
and beyond.  
Participants in the intervention group received THPP in addition to EUC. THPP was developed during 
a two-year formative research phase.11,15 Two major adaptations, related to the content and delivery 
mechanism, were made to the original THP intervention to make it deliverable by peers. Firstly, we 
shifted the focus from CBT (the active ingredient of the original THP intervention) to behavioural 
activation, because formative research indicated that CBT is more difficult for lay providers such as 
peers to learn.11 Secondly, we reduced the number of sessions. THPP was delivered over 6-14 
individual sessions in four phases over 7-12 months depending on the eligible trimester of 
recruitment, with sessions lasting between 30 and 45 minutes each. The four phases were: 1) prenatal 
phase focusing on the second or third trimester of pregnancy in which one to six sessions were 
delivered; 2) early infancy (first two months after childbirth; one to four sessions); 3) middle infancy 
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(three to four months post-childbirth; two sessions); and 4) late infancy (five to six months post-
childbirth; two sessions). Treatment completion was defined as receiving a minimum of six sessions 
with at least one session within each of the four phases.  
The peers who delivered THPP were lay women (i.e. without any mental health training) who have 
shown an interest or desire to help and support other women within their community). They were 
middle-aged with children, and showed  a similar socio-demographic background as participants and 
had good communication skills; they were referred to as “Sakhi” which translates to “friend” in Hindi. 
Additional criteria of Sakhis are published elsewhere.15 Sakhis were recruited from the local 
community through word-of-mouth, particularly through key informants in women’s self-help groups 
and CHWs responsible for the well-being and nutrition of mothers and their new-borns.  
In total, 26 Sakhis entered the trial and each received 25-40 hours of classroom-based training focusing 
on intervention content and relationship-building skills. This included sessions on dealing with difficult 
situations, recognition of symptom worsening, and serious adverse events (SAEs). Training was 
primarily interactive and comprised discussion and role-plays. A clinical internship period of two 
months followed the training, during which Sakhis delivered two to four sessions of THPP to at least 
two mothers.  At the end of their training and internship period, Sakhis were assessed on their 
competence using standardized role plays. Only Sakhis who passed pre-defined competence levels 
were selected for THPP delivery. Sakhis and trial participants were matched by location, i.e. a Sakhi 
delivered THPP to participants living closest to them. THPP sessions were delivered at the participant’s 
home, unless the participant chose a different venue for intervention delivery. If a Sakhi’s caseload 
exceeded four women, the next closest-living Sakhi was chosen. Sakhis were instructed to schedule 
their first sessions with the participants within three days of recruitment.  
 
During the trial, Sakhis continued to receive fortnightly group supervision sessions (with four to five 
Sakhis per group), once a month with a supervisor present and once a month without a supervisor 
being present. A peer group leader was chosen on a rotation basis at each session to lead the 
discussion; when the supervisor was present the peer group leader and supervisor co-facilitated the 
session together. An audio-recorded THPP session delivered by a Sakhi was played at each session, 
and successes and difficulties were discussed. The audio-recordings were rated on the Therapy Quality 
Scale (TQS)21, and feedback was exchanged in the group.  
 
In addition, audio-recordings of a random sample of 5% of sessions stratified by phase were rated on 
the TQS21 by independent raters experienced in CBT. The mean score across 18 items (0-2) was used 
to monitor quality of intervention delivery. Other fidelity measures included the number and duration 
of sessions delivered, number of participants who completed treatment, and number of participants 
who were treatment failures (and were referred to specialist mental health care).   
 
Outcomes 
Primary outcomes were symptom severity (PHQ-9 score) and remission (PHQ-9 score <5) assessed at 
6 months post-childbirth. Remission was originally defined as PHQ-9 score <10 in the published trial 
protocol10; however, this was amended to PHQ-9 score <5 as a more robust and clinically meaningful 
measure of remission17 after discussion with the TSC and prior to finalisation of the analysis plan. We 
confirmed that we would have adequate power for this outcome in October 2016, using data from 
the 6 months outcome data in the initial 136 participants, pooled across the arms. Approval for this 
change was obtained from the Data Safety Monitoring Board (DSMB) of the National Institute of 
Mental Health (NIMH) and the IRBs before unblinding.  
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Secondary outcomes were symptom severity and remission at 3 months and recovery (PHQ-9 score 
<5 at both 3 and 6 months). Further secondary outcomes at 3 and 6 months were disability (WHO 
Disability Assessment Schedule, WHO-DAS score), number of days unable to work in the last month, 
maternal support (Multidimensional Scale of Perceived Social Support, MSPSS score), exclusive 
breastfeeding (WHO definition, namely feeding breastmilk exclusively in the previous 24 hours), and 
infant weight- and height-for-age assessed with z-scores. Minimal clinically important difference 
(MCID) was assessed by asking participants how much of their tension had changed since entering the 
study. We also collected information on SAEs (death of the participant due to any cause, loss of child, 
suicide attempt, hospitalisation, victimisation, infant abuse/neglect, stigmatization and reported 
violence towards others). 
A tailored version of the Client Service Receipt Inventory (CSRI) (a copy can be made available from 
the corresponding author) was used as an interviewer-administered measure to collect self-reported 
information on health service use, including the intervention, at 3- and 6-months post-childbirth for 
the purpose of estimating costs and cost-effectiveness of the intervention. 22Evaluation of costs and 
effects was based on both a health system and a broader societal perspective. Health system costs 
were derived from in-patient and out-patient costs, costs of laboratory tests and investigations, 
medications, and intervention delivery costs (that is, time taken by Sakhis to deliver each THPP 
session, including training and supervision, plus travel time and transportation costs for home visits 
including ‘no-shows’). Societal costs encompassed these health system costs and also time and 
productivity costs of mother’s time out of usual activities because of their health, as well as time costs 
for mothers (and accompanying family members) related to the use of health services. Care-giver and 
mother’s time-costs were valued using the human capital approach making use of different daily wage 
rates recommended in 2015 by the Indian Office of the Labour Commissioner (see appendix O for a 
summary of unit costs of these wage group classifications). Unit costs for doctor contacts and inpatient 
stays were inflated (using International Monetary Fund consumer price index) to 2015 prices using 
unit costs that had previously been used for an economic evaluation in Goa.23 Unit costs of counselling 
sessions by peers and other health care services were calculated on the basis of local facility records 
using simplified costing templates (see appendix O for a summary of unit costs used in this analysis). 
Costs were evaluated and reported for three periods of time: 1) the 6-month period of service use 
covering the third trimester and the first 3 months post-childbirth; 2) the 3-month period of service 
use since the 3-month post-childbirth assessment; and 3) the 9-month period of service use covering 
the third trimester and the first 6 months post-childbirth (that is, the total period of the trial).  
 
Statistical analysis  
As per our trial protocol, assuming an intra-cluster correlation (within-peer counsellor clustering) of 
0.05 in the intervention group, 25-30 peers, and loss to follow up of 15%, 280 participants would 
provide 84% power to detect a difference for the primary outcome of remission of 78% in the THPP 
plus EUC group compared to 60% in the EUC alone group; and 84% power to detect a standardised 
mean difference (SMD) of 0·4 for the primary outcome of PHQ-9 score/symptom severity.10 The 
original sample size calculations were based on remission (defined as PHQ-9>10) in the THP trial in 
Pakistan8 and conditional power was estimated based on blinded preliminary data from 134 
participants (prevalence of 67% across the two arms); for symptom severity it was also based on the 
THP trial in Pakistan8 (using the THP Hamilton Depression Rating Scale at 6 months: THP group mean 
4·5, SD 6·0; control group mean 8·7, SD 7·4). We assumed a more conservative effect size to allow for 
the possibility of contamination between arms and a diluted effect due to the delivery of the 
intervention by Sakhis.  
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Outcomes were analysed on an intention-to-treat basis, among complete cases and adjusted for 
recruitment centre (with the primary health centres combined due to low frequencies), baseline PHQ-
9 score, and residence (urban/rural) a priori, plus those showing imbalance at baseline (treatment 
expectations, education and chronicity). For continuous outcomes, we used linear regression models, 
with results reported as standardised mean differences (SMD). The SMDs were calculated as the mean 
difference from the adjusted regression model divided by the pooled standard deviation. For 
categorical outcomes, we used logistic regression models, with results reported as prevalence ratios 
(PR), estimated using the marginal standardisation technique, with 95% CIs estimated using the delta 
method.24 For each primary outcome, we assessed effect-modification of treatment effect with a 
priori-defined potential moderators and we performed repeated measures analyses (pooling the 3 
and 6 months results) using generalised estimating equations to account for within-person 
correlations. We estimated MCID as a patient-centered metric that captures both the magnitude of 
improvement and the value the patient places on that improvement, using an anchor-based 
approach25 via a receiver operating characteristic (ROC) curve. That is, we examined the cut points for 
relative reduction in PHQ-9 at 6 months versus baseline for sensitivity and specificity against the “gold 
standard” of the mother’s subjective sense of improvement, classified as better if answered “a lot 
better” or “a little better”.26Windows of -1 to +2 months were permitted for the follow-up visits; in 
sensitivity analyses these were restricted to -0.5 to +1 months. Sensitivity analyses included multiple 
imputation for missing outcome data, adjustment for clustering by Sakhi using generalised estimating 
equations, and fitting alternative models for PHQ-9 score, which had a positively skewed distribution 
(Poisson with robust standard errors, and negative binomial, respectively).   
Cost and cost-effectiveness was evaluated at 3 and 6 months post-childbirth, and for the period of the 
trial as a whole, both from the health system (health system costs) and societal perspective (health 
system costs plus impacts on the productivity of patients and their families). We used ordinary least 
squares regression models with margins in order to generate predicted means. All analyses were 
adjusted for the same baseline covariates as in the effectiveness analysis. Incremental cost-
effectiveness ratios (ICERs) and their respective confidence intervals were derived using a non-
parametric Monte-Carlo bootstrapping technique (with 1000 replications), involving random 
resampling of effectiveness outcomes and costs for intervention and control group.27 A distribution 
plot of mean incremental costs and effects was generated on a cost-effectiveness plane in order to 
examine the probability of the intervention being cost-effective.  
Statistical analyses were conducted using Excel 2016 and Stata 15 for the cost-effectiveness analyses, 
and all other analyses were conducted in Stata 14. The DSMB of the NIMH oversaw the study. The trial 
is registered with ClinicalTrials.gov, number NCT02104232.  
 
Data sharing 
Data from our trial has been made available at the LSHTM data repository available at 
http://datacompass.lshtm.ac.uk/ (doi:10.17037/DATA.00000793). 
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Role of the funding source 
The funder of the study had no role in study design, data collection, data analysis, data interpretation, 
or writing of the report, except for LNP who was a Scientific Collaborator, under the cooperative 
agreement that funded the research. DCF, VP, FV, HAW, BW and ES had full access to trial data. DCF 
and VP had final responsibility for the decision to submit for publication.  
 
 
RESULTS  
Between 24th October 2014 and 22nd June 2016, 118,260 women were assessed for eligibility and 
6369 (5%) were screened using the PHQ-9, of whom 333 (5%) screened positive (PHQ-9 score ≥10; 
Figure 1). A total of 280 (84%) women consented, and were enrolled, with 140 randomly allocated to 
each group. Baseline characteristics were broadly similar by treatment group (Table 1). The median 
PHQ-9 score was 13 in the THPP plus EUC group and 12 in the EUC group, the mean age was 25 years, 
all participants but one were married, the majority (85%) were not working and most (87%) did not 
have schooling beyond secondary school. There was no evidence of a difference in baseline 
characteristics between participants and those who declined (appendix A).  
 
Overall, 122 (87%) women in the THPP plus EUC group contributed primary outcome data at 6 months, 
compared to 129 (92%) in the EUC group (p=0.17; Figure 1). There was no evidence of a difference in 
baseline characteristics by having 6-month outcome data or not (appendix B), nor by having the visit 
in the protocol-defined window (appendix C). The final 6-month visit was completed on 9th June 2017.  
 
We observed a modest effect of the intervention on the prevalence of remission at 6 months (89 (73%) 
versus 77 (60%); PR=1·21; 95%CI 1·01 to 1·45; p=0.04; Table 2). There was weak evidence of an 
intervention effect on symptom severity at 6 months (mean PHQ-9 score 3·47 (standard deviation (SD) 
4·49) versus 4·48 (SD 5·11); SMD=-0·18, 95% CI -0·43 to 0·07; p=0.16). We found some evidence of 
effect modification of remission by chronicity of depression (p=0.04) with women showing shorter 
duration of  chronicity being more likely to respond; no other effect moderation was observed 
(appendices D and E). Primary outcome results were robust to sensitivity analyses restricting the 
analysis window (appendix F), adjustment for clustering by therapist, alternative model specifications, 
and imputation for missing values (appendices G and H respectively).  
 
Figure 2 shows the intervention effect on remission and recovery by group over 6 months. There was 
evidence of intervention effects on depression symptom severity at 3 months (SMD=-0·34, 95%CI -
0·59 to -0·09, p=0·01), on disability scores (SMD=-0·34, 95%CI -0·59 to -0·10, p=0·009) and social 
support scores (SMD=0·32, 95%CI 0·06 to 0·57, p=0·02) at 3 months, and on social support scores at 6 
months (SMD=0·27, 95%CI 0·02 to 0·52, p=0·04). There was evidence of intervention effects on 
recovery (PR=1·35, 95%CI 1·03 to 1·78, p=0·03), and weaker evidence of an intervention effect on 
remission at 3 months, , and WHO-DAS score at 6 months (p=0·08, 0·16, and 0·16, respectively). 
Secondary outcomes presented as adjusted mean differences and odds ratios are presented in 
appendix I. MCID analyses are included in appendix J. 
There was no evidence of an intervention effect at either 3 or 6 months on other secondary outcomes 
(i.e. the number of days unable to work in the last month (p=0·98 and 0·70, respectively), 
breastfeeding (p=0·41 and 0·65) or infant weight (p=0·42 and 0·84) and height (p=0·58 and 0·89)).  
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In repeated measures analyses, we found no evidence of group-by-time interactions and therefore 
assumed a constant intervention effect at 3 and 6 months (Appendix K). This showed evidence of a 
beneficial  intervention effect on symptom severity (SMD -0·37, 95% CI -0·88 to -0·24, p=0·01), 
prevalence of remission (PR=1·21, 95% CI 1·01 to 1·41, p=0·02), WHO-DAS score (SMD=-0·32, 95% CI 
-0·76 to -0·21, p=0·02), and MSPSS score (SMD=0·51, 95% CI 0·43 to 1·20, p=0·02) but no evidence of 
an effect on number of days unable to work in the last month (p=0·77) (see table 3).  
Overall, 51 (18%) participants had at least one SAE, with the most common being hospitalisations, 
victimisation and stigmatisation (appendix L). There was no evidence of any differences between the 
groups, except stigmatisation was somewhat more often reported in the EUC alone (9%) than the 
THPP plus EUC group (4%; p=0·08).  
The overall mean number of sessions attended by participants in the intervention group was 9·8 (95% 
CI 9·1 to 10·6), with a mean duration of 38 minutes. The mean number of sessions attended in phase 
one was 4·5 out of a possible six sessions (95% CI 4·2 to 4·8), in phase two out of four sessions, 2·5 
(95% CI 2·2 to 2·8), in phase three out of two sessions, 1·4 (95% CI 1·3 to 1·6), and in phase four out 
of two sessions, 1·4 (95% CI 1·3 to 1·6). 99/138 (72%) participants met the criteria for treatment 
completion and 14/122 (11%) were treatment failures (participants in the intervention group needing 
referral to specialist mental health care at the end of treatment at 6 months either because of clinical 
deterioration or lack of improvement). The mean therapy quality score as determined by independent 
raters was 1·51 (95% CI 1·40 to 1·62) (n=42) indicating average to good therapy quality.  
The mean cost of providing THPP was US$ 1·36 per beneficiary (95% CI 1·32 to 1·39) and 12% of this 
cost was attributed to incentives alone (appendix M). When other health care costs (health system 
perspective) and time and productivity costs were added (societal perspective), costs were 
appreciably (but not statistically significantly) lower in the THPP plus EUC group at 3 and 6 months 
post-childbirth (table 4). The adjusted mean difference in societal cost was -US$ 53·98 (95% CI -109·64 
to 1·68) and -US$17·69  (95%CI -45·94 to 10·54) at 3 and 6 months post-childbirth, respectively. 
Combining these cost findings with the primary outcome measure of symptom relief gave rise to 
dominant and, in some cases, also statistically significant ICERs; at 3 months post-childbirth, the 
incremental societal cost per unit improvement on PHQ-9 was –US$ -29·64 (-32·88 to -26·41) and for 
the whole period of the trial it was –US$ 93·53 (95%CI -180·21 to -6·84), indicating that THPP is a cost-
saving intervention strategy (table 4). At 6 months post-childbirth, though THPP plus EUC was not 
cost-saving in the sense of better outcome and lower cost, it was still cost-effective, with cost-
effectiveness planes revealing that THPP plus EUC has an 87% chance of being both more effective 
and less costly than EUC alone when a societal perspective  is adopted (Figure 3B) and a 72% chance 
under a health system perspective (Figure 3A). ICERs for remission and recovery also demonstrated 
that THPP plus EUC was cost-saving; for example, the incremental cost per additional recovered case 
is –US$ 151·07  (health system perspective) and –US$ 736 (societal perspective).  Costs per beneficiary 
(appendix M), and service use patterns (table 1) and the costs of health care as well as foregone time 
and productivity (table 2) are detailed in appendix N for the intervention and control group at 3 and 6 
month post-childbirth, respectively.   
  
 
DISCUSSION 
THPP, a psychological intervention for the treatment of moderate to severe perinatal depression, 
delivered by peers (Sakhis) in community settings in Goa, India, produced better outcomes than EUC 
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alone, and led to moderate effects on clinical, social and functional outcomes over six months post-
natal. THPP was effective in reducing symptom severity of depression. THPP was of greater benefit to 
women with shorter duration of chronicity. THPP enhanced remission at 6 months following childbirth 
and promoted recovery from depression over the post-natal period. THPP significantly improved 
perceived social support and reduced disability in the post-natal period, in particular over the early 
post-natal period, but had no effect on the other pre-specified outcomes of the number of days unable 
to work in the last month, breastfeeding practices, and infant weight and height. Another important 
finding is that it costs only a little over a dollar (US) per beneficiary mother to provide THPP (12% of 
this cost is attributed to incentives), and when this is done, THPP not only leads to an improvement in 
depression severity and recovery but also pays for itself through reduced health care, time and 
productivity costs.  
First, we conclude that lay women in the community can be trained and empowered to deliver first 
line psychological care to depressed mothers in this urban setting of a relatively low resource country. 
This finding is of public health relevance as this may give rise to a new cadre of health care workers 
able to tackle the treatment gap of maternal depression in India. We found that incentives for lay 
health care workers and contextual differences between the more urban Indian and predominately 
rural Pakistan setting need to be taken into account when designing intervention delivery. Incentives 
for women living in urban Goa were financial rewards compared to rural Rawalpindi where altruistic 
motives were of greater importance.15 Evidence shows that the type of remuneration is indeed 
context-specific and has implications for the acceptability and sustainability of the intervention, and 
its scaling up.28 Second, we observed that the reduction in symptom severity was greatest within the 
first 3 months post-childbirth. This may be explained by the intervention architecture which involved 
front-loading of sessions provided antenatally and soon after childbirth—during which period 
participants received 80% of the total dose of the intervention. In addition to the dose, the content of 
the intervention was also front-loaded. THPP focussed on three main content areas (personal health 
of mothers, her relationship with her baby, and her relationship with others around her) which were 
delivered over four phases. While all three content areas were addressed in the first three phases, the 
purpose of phase four, delivered after three months post-natal, was to review the previous phases, 
and discuss relapse prevention; therefore, new content was not included during the last phase of the 
intervention. Third, we observed that a high proportion (60%) of participants in the control group 
showed remission at 6 months which also accounted for waning intervention effects at 6 months 
compared with 3 months, as observed in other perinatal depression trials.29,30 The most likely 
explanation for this remission is the natural history of the condition, in particular for mild and 
moderate cases.31 In addition it may be plausible that some non-specific elements, for example the 
participation in the research interviews or the enhancement of usual care, may have mediated 
symptom improvement. Fouth, although there was an effect on mother’s severity of depression, no 
significant difference on baby’s weight and height for age was observed. Similar results were found in 
the original THP study8 and in other trials32 and we assume that there may be other potent 
determinants of these outcomes, notably poverty,6 which our intervention did not address. 
Additionally, there were no differences in the proportion of mothers exclusively breastfeeding in the 
previous 24 hours. We found that the internal validity of the study was high; the trial conduct and 
analyses were done in accordance with the protocol, and there was a high participation rate, high 
adherence to the intervention with good fidelity of the intervention delivery, and low attrition.  
There are some limitations of our study. First, we did not employ diagnostic interviews to ascertain 
depression. Instead, we have used the PHQ-9, a validated screening tool that is simple to administer 
and has been used successfully in other depression trials in India.18 It has been validated in perinatal 
depression populations in other LMIC such as in Ghana33 or Pakistan34 and shows acceptable criterion-
11 
 
related validity and reliability for screening for depressive symptoms among women in the antenatal 
and postnatal period. Second, our study was conducted in a state with relatively high literacy levels. 
Generalizability and acceptability of peer-delivered psychological treatments, including training and 
supervision procedures may therefore differ when conducted among populations living in poorer 
socio-demographic circumstances, and in different health systems contexts. Third, we note that our 
control arm was well resourced and thus the effects of the intervention might be even larger in less 
resourced settings, for e.g. where obstetric care is not provided by gynaecologists. Fourth, we 
assumed a constant intervention effect of THPP during the study duration as we did not find evidence 
of group-by-time interactions; however, this may be due to lack of power to detect interaction. Finally, 
a true intention-to-treat analysis was not possible due to missing outcome data for about 10% of 
participants, but the results using complete case analysis adjusted for factors associated with 
missingness (primary analysis) and multiple imputation analysis (Appendices G and H) were similar. 
 
We have shown that a psychological intervention based on behavioural activation delivered by peers 
is effective in reducing the severity of symptoms of perinatal depression and promoting recovery from 
depression after childbirth, is relatively cheap to deliver and pays for itself, and leads to improved 
functional outcomes and social support. Women with postpartum depression represent a 
heterogenous group of clinical subtypes who need diverse interventions to improve long-term 
treatment outcomes.35 Therefore, our intervention may be conceputualized as the front-line, first 
step, intervention, in a stepped care system for maternal depression. We argue that mothers who 
show no response after the first three months of THPP should be offered a higher frequency of 
sessions during the final three months of treatment and/or should be stepped-up to a more intensive 
intervention delivered by a specialist provider. Further research should explore if early response 
predicts long-term outcomes, which might pave the way for more personalized allocation of treatment 
options, which could start with provision of THPP to all women with perinatal depression, 
discontinuation of early responders after a few sessions, and more intensive interventions for non-
responders after the first three months of treatment. Such a programme would allow the recovery of 
as many mothers as possible through the stepped allocation of treatments of different intensities and 
would be tailored to individual need and response. Replications of THPP are essential to further the 
evidence on the use of THPP in different contexts, and this will need to include adaptations to ensure 
context-specific determinants of perinatal depression are addressed during implementation (e.g. 
addressing domestic violence). Finally, we note the high concordance of results between the two trials 
implemented concurrently in two distinct settings in India (urban/peri-urban) and Pakistan 
(predominantly rural)12, providing evidence of the external validity of our results. We conclude that 
THPP is low cost and widely accessible, so that even despite the modest effects we have observed, its 
scale up can have significant public health impact. Our results also support the WHO’s 
recommendation for the use of THP, and offer evidence of the potential to scale-up its delivery using 
widely available and low-cost community resources such as peers.  
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RESEARCH IN CONTEXT 
Evidence before this study Systematic reviews provide robust evidence that perinatal depression 
can be effectively managed with psychological treatments, and there is increasing evidence that 
non-specialist health workers can effectively deliver such interventions. We conducted a systematic 
review to update earlier evidence on the topic to assess the effect of (non-pharmacological) 
psychological interventions on common perinatal mental disorders in LMIC. Seven electronic 
bibliographic databases including MEDLINE, EMBASE, CINAHL, PsycINFO, the British Nursing Index, 
the Allied and Complementary Medicine database and the Cochrane Central Register were 
searched from 1 January 2012 – 1 January 2018 combining search terms for depression and 
controlled evaluations. The search was restricted to English articles and studies conducted in LMIC. 
17 trials on perinatal depression were retrieved. The pooled effect size was -0.695, 95% CI= -0.92 
to -0.47 for maternal depressive symptoms. The studies employed a range of delivery agents, 
including CHWs; however, none of the studies employed peers as delivery agents for the 
intervention. The largest reported effects have been achieved by the Thinking Healthy Program 
(THP), delivered by community health workers (CHWs) to depressed mothers in rural Pakistan. The 
intervention based on cognitive behaviour therapy more than halved the rate of depression 
compared with usual care and led to significant improvements in women’s functioning and 
disability. Efforts to integrate the intervention in the CHW’s daily routine at scale was however 
compromised by multiple health care responsibilities of CHWs. Feasibility and delivery of this 
intervention by lay health care providers such as peers remained unclear.  
Added value of this study We adapted the Thinking Healthy Programme for delivery by peers 
(THPP). This study showed that the adapted intervention, whose focus was primarily on behavioural 
activation, was acceptable to participants and feasible to deliver by lay women in the community 
who had no previous health background. The intervention produced better outcomes than 
enhanced usual care and led to moderate effects on clinical, social and functional outcomes. THPP 
was highly cost-effective in this setting.  
13 
 
Implications of all the available evidence Psychological interventions like THPP may be considered 
for scaling up through peer workers as the first stage of care in a collaborative stepped care model 
for perinatal depression. 
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Figures and Tables 
 
Figure 1: Trial profile  
 
 
THPP= Thinking Healthy Programme delivered by peers. EUC=enhanced usual care. PHQ-9=Patient Health Questionnaire 9. 
Child deaths indicated at month 6 include those reported at month 3. Of those reported moved away permanently at 
month 3, 3 women in each of the groups returned at month 6. One woman in the EUC group attended her 6 month visit at 
8.1 months (therefore excluded from the primary endpoint analysis). 
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Table 1: Baseline characteristics  
 THPP plus EUC (N=140) EUC alone (N=140) 
Recruitment site (n [%]) 
GMC hospital 
Asilo hospital 
Bicholim PHC 
Sanquelim PHC 
 
70 (50%) 
63 (45%) 
6 (4%) 
1 (1%) 
 
71 (51%) 
62 (44%) 
7 (5%) 
0 
Residence (n [%]) 
Rural  
Urban 
 
103 (74%) 
37 (26%) 
 
103 (74%) 
37 (26%) 
Age, years (mean [SD]) 25·04 (4.42) 25·31 (4·74) 
Marital status (n [%]) 
Married 
Divorced/separated 
 
139 (99%) 
1 (1%) 
 
140 (100%) 
0 
Occupation (n [%]) 
Does not work 
Manual worker 
Non-manual worker 
 
119 (85%) 
15 (11%) 
6 (4%) 
 
118 (84%) 
15 (11%) 
7 (5%) 
Education status (n [%]) 
No formal education 
Completed primary 
Completed secondary 
Completed higher secondary 
Graduate/above 
 
21 (15%) 
55 (39%) 
44 (31%) 
13 (9%) 
7 (5%) 
 
13 (9%) 
65 (46%) 
46 (33%) 
12 (9%) 
4 (3%) 
Patient’s expectation of usefulness of 
counselling (n [%]) 
Not useful 
A little useful  
Somewhat useful 
Moderately useful 
Very useful 
 
 
1 (1%) 
25 (18%) 
22 (16%) 
30 (21%) 
62 (44%) 
 
 
0 
30 (21%) 
32 (23%) 
28 (20%) 
50 (36%) 
Chronicity of depression category (n 
[%]) 
<12 weeks  
≥12 weeks 
 
83 (59%) 
57 (41%) 
 
90 (64%) 
50 (36%) 
PHQ-9 score 
Median [IQR] 
 
13 [11 to 15] 
 
12 [11 to 15] 
PHQ-9 score category (n [%]) 
10-14 (moderate) 
15-19 (moderately severe) 
20-27 (severe) 
 
97 (69%) 
32 (23%) 
11 (8%) 
 
100 (71%) 
35 (25%) 
5 (4%) 
PHQ question 10 (n [%])1 
Not difficult at all 
Somewhat difficult 
Very difficult 
Extremely difficult 
 
22 (16%) 
82 (59%) 
15 (11%) 
21 (15%) 
 
21 (15%) 
83 (59%) 
12 (9%) 
24 (17%) 
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 THPP plus EUC (N=140) EUC alone (N=140) 
MSPSS score (mean [SD])  5·31 [1·11] 5·27 [1·11] 
Parity (n [%]) 
Primiparous  
Multiparous 
 
61 (44%) 
79 (56%) 
 
58 (41%) 
82 (59%) 
Previous non-live birth (n [%]) 
None  
One/more 
 
131 (94%) 
9 (6%) 
 
130 (93%) 
10 (7%) 
Any domestic violence in last three 
months (n [%]) 
No  
Yes  
 
124 (89%) 
16 (11%) 
 
119 (85%) 
21 (15%) 
Time between screening and birth of 
child, months (mean [SD]) 2 
Missing   
 
3·87 [1·66] 
8 (6%) 
 
3·93 [1·64] 
3 (2%) 
[1] Question: If you checked off any problems (PHQ questions 1-9), how difficult have these problems made it for you to do 
your work, take care of things at home, or get along with other people? [2] Women who did not attend any follow up visits 
have missing information relating to the date of birth of the child. MSPSS=Multidimensional Scale of Perceived Social 
Support. THPP= Thinking Healthy Programme delivered by peers. EUC=enhanced usual care. PHQ-9=Patient Health 
Questionnaire 9. SD=Standard Deviation. IQR=Interquartile range. GMC=Goa Medical College. PHC=Primary health care. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
17 
 
Table 2: Primary and secondary outcomes  
 THPP plus 
EUC 1 
(n=122)* 
EUC alone 1 
 
(n=129)* 
Standardised mean 
difference (SMD) or 
prevalence ratio (PR) 
(95% CI) for THPP plus 
EUC versus EUC alone 2 
p-value 
Primary outcomes  
PHQ-9 score at 6 
months 
3.47 (4.49) 4.48 (5.11) SMD=-0·18 (-0·43 to 0·07) 0·16 
Remission (PHQ-9 
score <5) at 6 months 
89 (73%) 77 (60%) PR=1·21 (1·01 to 1·45) 0·04 
Secondary outcomes  
PHQ-9 score at 3 
months 3 
4.26 (4.23) 5.81 (5.74) SMD=-0·34 (-0·59 to -
0·09) 
0·01 
Remission (PHQ-9 
score <5) at 3 months 
74/123 
(60%) 
62/122 
(51%) 
PR=1·22 (0·97 to 1·52) 0·08 
Recovery (PHQ-9 score 
<5 at both 3 and 6 
months) 
61/116 
(53%) 
49/120 
(41%) 
PR=1·35 (1·03 to 1·78) 0·03 
WHO-DAS score      
3 months 3 11.86 
(13.29) 
16.17 (15.48) SMD=-0·34 (-0·59 to -
0·10) 
 
0·009 
6 months 4 9.47 (11.91) 12.11 (13.65) SMD=-0·18 (-0·43 to 0·07) 
 
0·16 
Number of days unable 
to work in last month  
    
3 months 3 2.10 (5.20) 2.07 (4.88) SMD=0·00 (-0·25 to 0·25) 0·98 
6 months 4 2.47 (5.61) 2.72 (5.53) 
[4] 
SMD=-0·05 (-0·30 to 0·20) 0·70 
MSPSS score      
3 months 5 5.65 (1.07) 5.30 (1.12) 
[5] 
SMD=0·32 (0·06 to 0·57) 0·02 
6 months  4 5.59 (1.12) 5.27 (1.20) 
[4] 
SMD=0·27 (0·02 to 0·52) 0·04 
Exclusive breastfeeding 
in last 24 hours  
    
3 months 86/121 
(71%) 
82/122 
(67%) 
PR=1·07 (0·91 to 1·27) 0·41 
6 months 9/121 (7%) 10/128 (8%) PR=0·82 (0·35 to 1·92)  0·65 
Infant weight for age z 
score 
    
3 months 6 -1.21 (0.95) -1.30 (1.05) SMD=0·11 (-0·15 to 0·37) 0·42 
6 months 7 -1.03 (0.88) -1.05 (1.03) SMD=0·03 (-0·23 to 0·29) 0·84 
Infant height for age z 
score 
    
3 months 6 -0.38 (1.23) -0.30 (1.10) SMD=-0·08 (-0·34 to 0·18) 0·58 
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6 months 7 -0.43 (1.12) -0.42 (1.13) SMD=-0·02 (-0·28 to 0·24) 0·89 
[1] Results are mean (standard deviation) or number (%). [2] By linear or logistic regression, adjusted for recruitment 
centre, baseline PHQ-9 score, residence, treatment expectations, education and chronicity (see Methods). [3] N=123 and 
122 in the THPP plus EUC and EUC alone groups, respectively. [4] N=122 and 128 in the THPP plus EUC and EUC alone 
groups, respectively. [5] N=122 and 122 in the THPP plus EUC and EUC alone groups, respectively. [6] N=110 and 115 
in the THPP plus EUC and EUC alone groups, respectively. [7] N=106 and 122 in the THPP plus EUC and EUC alone 
groups, respectively. MSPSS=Multidimensional Scale of Perceived Social Support. THPP= Thinking Healthy Programme 
delivered by peers. EUC=enhanced usual care. PHQ-9=Patient Health Questionnaire 9. WHO-DAS=WHO -Disability 
Assessment Schedule. *Among those with observed outcome data at 6 months. Secondary outcomes as adjusted mean 
differences and odds ratios are presented in appendix I.  
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Figure 2: Intervention effect on remission and recovery by group over 6 months 
 
 
 
. EUC=Enhanced Usual Care. THPP=Thinking Healthy Programme Peer-Delivered. Remission defined as PHQ-9 score <5; 
recovery defined as PHQ-9 score <5 at both 3 and 6 months; P-values are from logistic regression models, adjusted for 
recruitment hospital, residence, baseline PHQ-9 score, treatment expectations, education, and chronicity of depression 
(see methods for more details).  
  
  
20 
 
Table 3: Intervention effect for depression, disability and social support outcomes analysed as 
repeated measures 
 
 P value for 
group by 
time 
interaction 
Overall adjusted 
SMD or PR (95% CI) 
for THPP plus EUC 
versus EUC alone1 
P value for 
overall 
effect 
Primary    
PHQ-9 score  0·32 -0·37 (-0·88, to 0·24) 0·01 
Remission (PHQ-9<5)  0·56 1·21 (1·01 to 1·41) 0·02 
Secondary    
WHO DAS score  0·44 -0·32 (-0·76 to -0·21) 0·02 
Number of days 
unable to work 
0·72 -0·03 (-0·30 to 0·20)  0·77 
MSPSS score 0·98 0·51 (0·43 to 1·20) 0·02 
[1] Adjusted for recruitment centre, baseline PHQ-9 score, residence, treatment expectations, education and chronicity 
(see Methods), and in addition visit, using generalised estimating equations to account for within-person correlations.. 
Standarised mean differences calculated using the mean difference from the adjusted GEE models divided by the standard 
deviation estimated from adjusted random effects model, with confidence intervals estimated using bootstrap with 1000 
replicates and percentile estimation. CI=confidence interval, PHQ=Patient Health Questionnaire, MSPSS= Multidimensional 
Scale of Perceived Social Support, WHO DAS=WHO Disability Assessment Schedule, AMD=Adjusted mean difference.  
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Table 4: Cost-effectiveness analysis from health system and societal perspectives at 3 months, 6 
months, and over the trial period. 
  Adjusted mean difference 
between THPP plus EUC and 
EUC alone at  
3 months  
post-childbirth 1 
(Mean, 95% CI) 
Adjusted mean difference 
between THPP plus EUC 
and EUC alone at  
6 months  
post-childbirth 2 
(Mean, 95% CI) 
Adjusted mean difference 
between THPP plus EUC and 
EUC alone over total period 
of trial 3 
(Mean, 95% CI) 
COSTS       
a)   Total health system costs 
(incl. intervention) 
US$ -11·03  
(-41·94 to 19·87) 
US$ -2·49 (-8·12 to 3·14) US$ -14·86 (-46·91 to 
17·19) 
b) Total Societal Costs (health 
system and productivity costs) 
US$ -53·98 (-109·64 to 
1·68) 
US$ -17·69 (-45·94 to 
10·54) 
US$ -72·41 
(-141·84 to -2·98) 
CLINICAL OUTCOMES       
1)   PHQ-9 summary score4 1·86 (0·53 to 3·18) -1·04 (-2·36 to 0·28) 0·73 (-0·57 to 2·02) 
2)  Additional number of 
mothers remitted in 
THPP (%):PHQ-9 score < 
5 at 3 or 6 months5  
12 (8·8%) 11 (6·6%) NA 
   3)   Additional number of 
patients recovered in THPP (%): 
PHQ-9 score < 5 at 3 and 6 
months  
12 (11%) 
  ICER  
(US$, 95% CI) 
ICER 
(US$, 95% CI) 
ICER 
(US$, 95% CI) 
COST-EFFECTIVENESS       
A.   Total health system costs 
(incl. intervention) 
      
·    Cost per unit improvement 
in PHQ-9 score 
-6·14 (-7·15 to -5·12)  2·44 (0·24 to 4·65)   -19·09 (-49·45 to 11·25) 
·    6Cost per additional case 
remitted 
-112·1 -27·6 NA 
·    7Cost per additional case 
recovered (over total 
trial duration) 
-151·07  
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B.   Total societal costs (health 
system and productivity 
costs) 
      
·    Cost per unit improvement 
in PHQ-9 score 
-29·64 (-32·88 to -26·41) 16·95 (5·56 to 28·35)   -93·53 (-180·21 to -6·84) 
·    6Cost per additional case 
remitted 
-548·8 -196·2 NA 
·    7Cost per additional case 
recovered (over total 
trial duration 
-736 
 [1] Cost and outcome estimates relate to the 6-month period covering the third trimester and the first 3 months post-
childbirth 
[2] Cost and outcome estimates relate to the 3-month period since the 3-month post-childbirth assessment 
[3] Cost and outcome estimates relate to the 9-month period covering the third trimester and the first 6 months post-
childbirth 
[4] Reduction in PHQ-9 scores converted to a positive change score to aid interpretation of cost-effectiveness results. 
[5] Out of total remitted in both arms 
[6] Estimated as: (cost difference*total number of mothers in THPP)/additional number of patients remitted in THPP arm. 
[7] Estimated as: (cost difference*total number of mothers in THPP)/additional number of patients recovered in THPP arm. 
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Figure 3. Cost-effectiveness planes: THPP plus EUC compared to EUC per unit improvement in depression severity score over total period of trial.  
 
Figure 3A: Health System Perspective                                           Figure 3B: Societal Perspective 
 
 
 
 
 
 
 
 
 
 
 
 
CS: Cost-saving  
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